ArticleNature cancer2026

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial.

Jun Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.